期刊文献+

星点设计-效应面法优化醋酸地塞米松脂质纳米粒的制备工艺 被引量:4

Optimization of the technological process to prepare Dexamethasone acetate lipid nanoparticles using central composite design-response surface methodology
原文传递
导出
摘要 目的优化醋酸地塞米松脂质纳米粒(DXMA-NLC)的制备工艺。方法采用薄膜超声法制备DXMA-NLC。以投药量、表面活性剂的浓度和大豆油的量为考察因素,以粒径和包封率为考察指标,根据星点设计原理安排实验,并用二项式拟合建立指标与因素之间的数学关系,经效应面法预测最佳工艺条件。结果采用15 mg DXMA、0.04 g·mL-1表面活性剂、100 mg大豆油制备DXMA-NLC,其粒径为156 nm、包封率为98.48%。结论按星点设计-效应面法优选的条件制备DXMA-NLC,得到与预测值相符的粒径与包封率,处方优化成功。 OBJECTIVE To determine the optimized formulation of DXMA-NLC.METHODS The film-ultrasonic wave dissolving technique was chosen to prepare DXMA-NLC.The amount of DXMA,the concentration of surfactants and the quantity of soybean oil were defined as the independent variables while the size and entrapment efficiency were defined as the dependent variables.Experiments were done based on the theory of central composite design.The data were simulated using second-order polynomial equation.The optimal formulation was predicted by response surface methodology.RESULTS The optimized formulation was 15 mg DXMA,0.04 g·mL-1 surfactants,100 mg soybean oil.According to the optimized formulation,DXMA-NLC was prepared,resulting in a particle size of 156 nm and entrapment efficiency of 98.48%.CONCLUSION Central composite design could achieve the desired particle size and entrapment efficiency of DXMA-NLC.
出处 《华西药学杂志》 CAS CSCD 北大核心 2011年第3期264-267,共4页 West China Journal of Pharmaceutical Sciences
关键词 醋酸地塞米松 脂质纳米粒 星点设计 效应面法 制备工艺 Dexamethasone acetate Lipid nanoparticles Central composite design Response surface methodology Technological process to prepare
作者简介 宋玉品(1986-),女,正攻读药剂学专业硕士学位。 通信作者(Correspondent author),Email:475089202@qq.com
  • 相关文献

参考文献6

二级参考文献16

  • 1陈燕忠,吕竹芬.盐酸二甲双胍缓释片处方筛选及工艺研究[J].药学进展,2004,28(8):366-369. 被引量:5
  • 2LiZHONG,Chao-mingLI,Xiao-jiangHAO,Li-guangLOU.Induction of leukemia cell apoptosis by cheliensisin A involves downregulation of Bcl-2 expression[J].Acta Pharmacologica Sinica,2005,26(5):623-628. 被引量:2
  • 3赵栋,龚涛,梁湖沂,陈琳琳,张志荣.星点设计-效应面优化法优化注射用Cheliensisin A冻干乳剂[J].华西药学杂志,2007,22(3):275-279. 被引量:11
  • 4Do B, Robinet S, Pradeau D,et al. Application of central composite designs for the chromatographic separation of monomethylarsonate and dimethylarsinate and selenome - thionine and selenite by ion - pair chromatography coupled with plasma mass spectrometric detection [J]. Analyst ,2001,13 (4) : 126 - 594.
  • 5Carolina Gomez-Gaete, Nicolas Tsapis, Madeleine Besnard,et al. Encapsulation of dexamethasone into biodegradable polymeric nanoparticles[J]. Int J Pharm, 331,2007:153-159.
  • 6K Yokoyama, M Watanabe. Limethason as a lipid microsphere preparation: An overview[J]. Adv Drug Deliv, Re. 20(1996) 195-201.
  • 7Alf Lamprecht, Jean-Louis Saumet, Jerome Rouxa,etal. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment[J]. Int J Pharrn,278,2004;407-414.
  • 8Ping Lia, Anasuya Ghosha, Robert F. Wagnera,et al. Effect of combined use of nonionic surfactant on formation of oil-inwater microemulsions[J]. Int J Pharm,288,2005 : 27-34.
  • 9Muller RH, Radtke M, Wissing SA. Nanostructrued lipid matrices for improved microencapsulation of drugs [J]. Int J Pharm, 2002,242:121-128.
  • 10P Kocbek,S Baumgartner, J Kristl. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs[J]. Int J Pharrn,312,2006: 179-186.

共引文献36

同被引文献31

  • 1滕小玉,管忠震,姚志文,刘冬耕,周宁宁,罗汉钰,Michael Hawkins,Patrick Soon-Shiong.晚期实体癌患者对不含聚氧乙烯蓖麻油注射用紫杉醇白蛋白纳米粒悬浮液的临床耐受性研究[J].癌症,2004,23(z1):1431-1436. 被引量:39
  • 2傅若秋,何凤慈,孟德胜,陈亮.紫杉醇聚乳酸纳米粒的制备[J].第三军医大学学报,2006,28(15):1573-1574. 被引量:4
  • 3张馨欣,操洪欣,甘勇,朱春柳,潘卫三.羟基喜树碱纳米脂质载体的制备及体外释放[J].中国医药工业杂志,2006,37(12):820-823. 被引量:11
  • 4Cheng XC, Liu XX, Xu WF, et al. Ligustrazine derivatives. Part 3 : Design, synthesis and evaluation of novel acylpiperazinyl deriv- atives as potential cerebrocardiac vascular agents[ J]. Bioorg Med Chem ,2009,17 ( 8 ) :3018 - 3024.
  • 5Tamilvanan S, Benita S. The potential of lipid emulsion for ocular delivery of lipophic drug [ J ]. Eur J Pharm Biopharm, 2004,58 (2) :357 -368.
  • 6Wang FH ,Zhang DR .Zhang Q ,et al. Synergistic effect of folate - mediated targeting and verapamil - mediated P - gp inhibition with paclitaxed - polymer micells to overcome multi - drug resist- ance [ J ]. Biomaterials ,2011,32 ( 35 ) :9444 - 9456.
  • 7Clericuzio M, Mella M, Vita-Finzi P, et al. Cucurbitane triterpenoids from Leucopaxillus gentianeus [J]. J Nat Prod, 2004, 67(11) : 1823-1828.
  • 8Tannin-Spitz T, Grossman S, Dovrat S, et al. Growth inhibitory activity of cucurbitacin glueosides isolated from Citrullus colocynthis on human breast cancer cells [J]. Biochem Pharmacol, 2007, 73 (1) : 56-67.
  • 9Souto EB, Wissing SA, Barbosa CM, et al. Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery [J]. Int J Pharm, 2004, 278 (1) : 71-77.
  • 10MUller RH, Radtke M, Wissing SA. Nanostructured lipid matrices for improved microencapsulation of drugs [J]. Int J Pharm, 2002, 242 (1-2) : 121-128.

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部